Home
Home

Dapagliflozin

This Undervalued Pharma Is Ready To Move Higher

This Undervalued Pharma Is Ready To Move Higher
Motley Fool

AstraZeneca's Forxiga For Type 2 Diabetes Is A Potential Blockbuster

AstraZeneca's Forxiga For Type 2 Diabetes Is A Potential Blockbuster
Seeking Alpha

J&J Experimental Diabetes Drug Helps High-Risk Patients

J&J Experimental Diabetes Drug Helps High-Risk Patients
Bloomberg

AstraZeneca Will Soar On 2 New Drugs In 2013

AstraZeneca Will Soar On 2 New Drugs In 2013
Seeking Alpha

Bristol-Myers, AstraZeneca announce results from Phase lll dapagliflozin study

Bristol-Myers, AstraZeneca announce results from Phase lll dapagliflozin study
Yahoo/The Fly On The Wall

19 Clinical Trials Aren't Enough

19 Clinical Trials Aren't Enough
Motley Fool

Bristol, AstraZeneca Diabetes Drug Fails to Win FDA Backing

Bristol, AstraZeneca Diabetes Drug Fails to Win FDA Backing
Bloomberg

9 Biotech Companies With FDA Approval Decision Dates In Q1 2012

9 Biotech Companies With FDA Approval Decision Dates In Q1 2012
Seeking Alpha

Bristol-Myers Presents Data

Bristol-Myers Presents Data
Yahoo/Zacks

22 Hot Drugs Facing FDA Approval in 2012

22 Hot Drugs Facing FDA Approval in 2012
TheStreet.com